(Q46657303)

24 December 2017

title

G1 arrest and expression of cyclin-dependent kinase inhibitors in tamoxifen-treated MCF-7 human breast cancer cells (English)

1 reference

24 December 2017

1 reference

Akira Ichikawa

1

1 reference

24 December 2017

Jiro Ando

series ordinal

2

1 reference

24 December 2017

Koichi Suda

series ordinal

3

1 reference

24 December 2017

publication date

1 May 2008

1 reference

24 December 2017

published in

Human Cell

1 reference

24 December 2017

volume

21

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

28-37

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1111/j.1749-0774.2008.00048.x

exact match

0 references

cites work

Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Additive effects of tamoxifen and the farnesyl transferase inhibitor FTI-277 on inhibition of MCF-7 breast cancer cell-cycle progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Antiestrogens are pro‐apoptotic in normal human breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Cell cycle checkpoints and their inactivation in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Inhibition of cyclin-dependent kinases by p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

The role of various Bcl-2 domains in the anti-proliferative effect and modulation of cellular glutathione levels: a prominent role for the BH4 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

EGF induces cell motility and multi-drug resistance gene expression in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

The Differential Effects of Cyclophosphamide, Epirubicin and 5-Fluorouracil on Apoptotic Marker (CPP-32), Pro-Apoptotic Protein (p21 WAF−1) and Anti-Apoptotic Protein (bcl-2) in Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

RB in breast cancer: at the crossroads of tumorigenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Molecular characterization of oncostatin M-induced growth arrest of MCF-7 cells expressing a temperature-sensitive mutant of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2008.00048.X

Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle

21 January 2018

1 reference

12 December 2020

Estrogen stimulates transcription of c-jun protooncogene.

1 reference

12 December 2020

The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer

1 reference

12 December 2020

Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time

1 reference

12 December 2020

WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis

1 reference

12 December 2020

Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects

1 reference

12 December 2020

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

12 December 2020

Participation of p53 protein in the cellular response to DNA damage

1 reference

12 December 2020

Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels

1 reference

12 December 2020

Cell death of MCF-7 human breast cancer cells induced by EGFR activation in the absence of other growth factors

1 reference

12 December 2020

Selective estrogen receptor modulators as inhibitors of repopulation of human breast cancer cell lines after chemotherapy

1 reference

12 December 2020

Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues

1 reference

12 December 2020

The presence of 19-kDa Bcl-2 in dividing cells

1 reference

12 December 2020

Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias

1 reference

12 December 2020

10.1111/J.1749-0774.2008.00048.X

Identifiers

DOI

1 reference

24 December 2017

Dimensions Publication ID

0 references

1 reference

24 December 2017